U-Hilix Soft Capsule 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 capsule (0.5mg) once daily. Because exposure to the contents of the capsule may cause irritation of the oropharyngeal mucosa, swallow the capsule whole without chewing or breaking it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. The recommended dose of this medicine in patients with hepatic impairment has not been established because there are no data on its administration to such patients.

This medication can be absorbed through the skin, so women who are pregnant or may become pregnant should not handle this medication directly. If the capsule is broken and the medication comes into contact with the skin, it should be washed off immediately with soap and water. Children should also avoid contact with this medication, and if contact occurs, they should also be washed immediately. Women, children under 18 years of age, and individuals allergic to this medication or similar components should not take this medication. Adult males planning to conceive should discuss with their doctor regarding the potential effects of this medication on fertility and use it with caution. Patients with urinary issues or liver function abnormalities should take this medication with caution, particularly observing for symptoms of urinary retention. Furthermore, when used in combination with certain potent medications, drug concentration may vary, so patients should inform their doctor about other medications they are taking. While taking this medication, side effects related to sexual function, such as erectile dysfunction, decreased libido, and ejaculation disorders may occur, and in some cases, these symptoms may persist even after discontinuation. Blood tests may show a reduction in prostate-specific antigen (PSA) levels due to this medication, so this should be considered when interpreting PSA test results. This medication may affect prostate cancer risk assessment, thus regular examinations are required, especially for males at risk of prostate cancer. Also, while the relationship between long-term use of this medication and male breast cancer occurrence is not clear, it is important to inform a doctor immediately if there are breast abnormalities. For those planning to donate blood, it is necessary to wait at least 6 months after the last dose of the medication, so this should be considered in planning donations. There is no specific antidote for overdose, so if overdose symptoms are suspected, immediate medical attention should be sought. This medication should be kept out of reach of children and stored in its original container to prevent misuse or deterioration of quality. While it is known not to affect driving or machine operation ability, caution is needed as individual differences may occur.

• erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• heart failure

This medication should be stored in a tightly sealed container to prevent air intrusion, preferably at a cool temperature below 30 degrees Celsius. This way, the effectiveness of the medication can be maintained for a longer period.

Appearance

For domestic use: A transparent yellowish oval soft capsule with colorless transparent contents. For export: An opaque cloudy yellow rectangular soft capsule containing colorless transparent contents.

Package unit

30 capsules (15 capsules/PTPX2)